Helping mainly technologically-advanced and sustainability-focused organizations to attract the investment and customer attention they deserve by linking investors with innovative organizations in a wide range of industries including Healthcare, Environmental, Mobility, Lifestyle, Green Technology, Energy and Space.

LIFE SCIENCES
With strong international credibility, world-class infrastructure, government support, and a leading position in sustainability and innovation, Sweden has earned a global reputation as a powerhouse in the life science sector. Sweedish Investment Group is a pioneering investment firm dedicated to building and scaling innovative Nutraceutical, Pharma, BioTech, and MedTech companies across the Nordics. Combining deep industry expertise with a hands-on approach, Sweedish Investment Group goes beyond traditional investment by offering strategic guidance, operational support, and access to a powerful integrated ecosystem designed to accelerate growth. Through its wholly owned subsidiaries and comprehensive network of services, the firm provides a 360-degree platform supporting companies from early-stage development and clinical advancement to commercialisation and global market expansion. Their mission is to empower breakthrough healthcare innovations with the expertise, partnerships, and resources needed to create lasting impact in life sciences.
With strong international credibility, world-class infrastructure, government support, and a leading position in sustainability and innovation, Sweden has earned a global reputation as a powerhouse in the life science sector. Sweedish Investment Group is a pioneering investment firm dedicated to building and scaling innovative Suppliment, Pharma, BioTech, and MedTech companies across the Nordics. Combining deep industry expertise with a hands-on approach, Sweedish Investment Group goes beyond traditional investment by offering strategic guidance, operational support, and access to a powerful integrated ecosystem designed to accelerate growth. Through its wholly owned subsidiaries and comprehensive network of services, the firm provides a 360-degree platform supporting companies from early-stage development and clinical advancement to commercialisation and global market expansion. Their mission is to empower breakthrough healthcare innovations with the expertise, partnerships, and resources needed to create lasting impact in life sciences.

and reforestation to deliver results that are in line with the UN Sustainable Development Goals. It specializes in giving clients advice on energy efficiency, clean energy options, tr
carbon market participants into a global ecosystem for financial and environmental gains, with a focus on energy, water, and food. It serves as a distributed hub and connective tissue to link multiple international carbon exchanges and other buyside carbon emitters and custodians with supply-side carbon offset projects and ESG project owners globally to drive distribution. For the purpose of keeping carbon credit ledger data up to date, their software also communicates with reputable third-party registries.
The firm’s platform matches investors with advanced learners by exploiting the fully scalable and high-return potential of non-loan Income Share Agreements (ISA’s). Investors in ISA’s may finely tune their investment criteria to match their corporate objectives, which may include CSR targets. Currently, the firm is proposing two types of investment opportunity: in the infinite possibilities of direct investments in ISA’s and, more conventionally, investments in shares (and, as the firm is designated by the French state as an innovative firm, offers the possibility of French residency/citizenship).
After a year of service, the e-ferry’s operators concluded that the system has a highly sustainable energy efficiency of 85%, almost twice that of diesel boats. With this background, the US$20 billion market expectation for electric watercraft seems more than reasonable. To support this industry, we are following a firm that has designed, and begun delivering, an electric-powered watercraft. Destined for the lucrative leisure market, this is a mere stepping stone to the huge water taxi market for which a design is already complete.
technology that detects one of the deadliest types of cancer and treats it without damaging healthy cells and tissues. Its electromagnetic stimulation, combined with a nanotechnology system, has demonstrated the preclinical treatment to be safe and effective. The medical device has been classified as class III to chronically treat and reduce cancer’s mass significantly from further development. The firm has started Phase I and seeking investments to support this phase. Based on Phase I results, which will be within 12-15 months, they plan an IPO for Phase II, the last one before the commercial launch in North America by 2024.





































